Search results
Gilead's long-acting HIV drug superior to daily pill Truvada in study
Reuters via AOL· 3 days ago(Reuters) -Gilead Sciences said on Thursday a late-stage study showed its long-acting injectable...
Drugs that treat HIV trialled in people with multiple brain tumours
PA Media: Science via Yahoo News· 3 days agoDrugs that treat HIV are being trialled for the first time in people with multiple brain tumours,...
DePaul Community Health Center providing free rapid tests for National HIV Testing Day
ABC 26 New Orleans· 2 days agoJune 27 is recognized as National HIV Testing Day and to celebrate, the Infectious Disease...
Gilead's twice-a-year HIV PrEP drug delivers stunning results in late-stage study - San Francisco...
The Business Journals· 3 days agoInjected only twice a year, an HIV PrEP drug developed by Gilead Sciences Inc. showed zero...
Data on HIV prevention drug helps stock surge
Gannett via AOL· 1 day agoGilead Sciences emerged as the week’s top-performing stock within the S&P 500 following the release of efficacy data for its potential HIV prevention...
Gilead Flashes Bullish Sign After HIV Drug Proves 100% Effective
Investor's Business Daily· 3 days agoThe news is a boon for Gilead Sciences (GILD), which already sells its HIV drugs Descovy and Truvada...
Column: Anthony Fauci has a right to savage Trump. His memoir takes a different and telling approach
Los Angeles Times· 11 hours agoAs director of the National Institute of Allergy and Infectious Diseases, he was at the red hot...
Gilead’s HIV prevention treatment found 100% effective in late-stage trial
Market Watch· 3 days agoGilead Sciences Inc.’s stock jumped early Thursday after the company said its experimental injection...
Fort Worth HIV survivors defy disease that once ensured death by growing old together
CBS News· 5 days agoHIV and AIDS used to be a death sentence for many in the 80s and 90s. One group of survivors gathers...
Gilead Shot Prevents 100% of HIV Cases in Trial of African Women
Bloomberg· 3 days agoGilead Sciences Inc.’s experimental twice-yearly shot prevented 100% of HIV cases in women and...